Patents
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
09/2002
09/03/2002US6444875 Imidazolinone resistant AHAS mutants
09/03/2002US6444871 Expression vector for use in the treatment and prevention of viral diseases
09/03/2002US6444804 Proteins involved in the synthesis and assembly of core lipopolysaccharide of Pseudomonas aeruginosa
09/03/2002US6444803 Bone mineralization proteins, DNA, vectors, expression systems
09/03/2002US6444802 Human aminopeptidase
09/03/2002US6444799 P. gingivalis polynucleotides and uses thereof
09/03/2002US6444792 CTLA4-Cγ4 fusion proteins
09/03/2002US6444790 Peptidoglycan recognition proteins
09/03/2002US6444460 Microbial production of actinol
09/03/2002US6444455 Stimulate phosphorylation and activation of substrates such as atf2, are provided. the polypeptides may be used, to identify antibodies
09/03/2002US6444454 Method for increasing the gene expression of saccharose synthase
09/03/2002US6444452 Process for recovering statin compounds from a fermentation broth
09/03/2002US6444451 Process for preparing amides
09/03/2002US6444449 Polynucleotides encoding proteins with d-sorbitol dehydrogenase activity or in vivo, vectors and recombinant organisms which contain such polynucleotides, and methods of making d-sorbitol dehydrogenase and l-sorbose.
09/03/2002US6444447 Polymer grafting by polysaccharide synthases
09/03/2002US6444446 Calcium binding proteolipid compositions and methods
09/03/2002US6444445 Genetic engineering
09/03/2002US6444444 Immunogenic composition, comprising at least one nucleic acid fragment as an active component thereof and vector for transformation of a host comprising the nucleic acid fragment
09/03/2002US6444438 Method for the preparation of a protein by yeasts using an inducible system, vectors and correspondence transformed strains
09/03/2002US6444437 Process for the production of nutritional products with microorganisms using sequential solid substrate and liquid fermentation
09/03/2002US6444431 Angiostatin receptor
09/03/2002US6444424 Pure thermostable dna polymerase from thermotoga neapolitana (tne). the tne dna polymerase has a molecular weight of about 100 kilodaltons and is more thermostable than taq dna polymerase. the present invention also relates to the cloning
09/03/2002US6444261 A particulate carrier for carrier-bound reactions, detection and/or isolation processes; used for immunoassay markers to bond a solid core by means of biopolymers to an affinity component; particles with usable properties, e.g. marking
09/03/2002US6444208 Ribonuclease III from Streptococcus pneumoniae
09/03/2002US6444206 Sepsis therapy; monoclonal antibodies
09/03/2002US6444204 Candida maltosa used for the bio-degradation of petroleum product pollutants
09/03/2002US6444202 Genetic engineering; immunsuppressants
09/03/2002CA2154274C Novel genes, polypeptides, and compositions for cold tolerance and drought resistance in plants
09/03/2002CA1341387C Human manganese superoxide dismutase (hmn-sod)
08/2002
08/29/2002WO2002066673A1 Method of preparing yeast for fermentation test
08/29/2002WO2002066664A2 Method for the production of d-pantothenic acid and/or salts thereof as adjunct for animal feedstuffs
08/29/2002WO2002066662A1 Process for the preparation of perillyl alcohol
08/29/2002WO2002066657A1 Method for the selection of recombinant clones comprising a sequence encoding an antidote protein to a toxic molecule
08/29/2002WO2002066654A2 Drug metabolizing enzymes
08/29/2002WO2002066653A2 Procaryotic libraries and uses
08/29/2002WO2002066652A2 Ehrlichia ruminantium polypeptides, antigens, polynucleotides, and methods of use
08/29/2002WO2002066650A2 Streptococcus pyogenes polypeptides and corresponding dna fragments
08/29/2002WO2002066649A2 ANTI-INTERFERON-α ANTIBODIES
08/29/2002WO2002066647A2 Type 2 ctokine receptor and nucleic acids encoding same
08/29/2002WO2002066646A2 Neurotransmission-associated proteins
08/29/2002WO2002066642A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
08/29/2002WO2002066641A1 Pg-3 and biallelic markers thereof
08/29/2002WO2002066638A1 Recombinant gene containing inverted repeat sequence and utilization thereof
08/29/2002WO2002066635A1 Transgenic animal having drug metabolism enzyme gene and utilization thereof
08/29/2002WO2002066630A1 Methods of modifying eukaryotic cells
08/29/2002WO2002066629A2 Recombinant vector containing infectious human cytomegalovirus genome with preserved wild-type characteristics of clinical isolates
08/29/2002WO2002066628A2 Supersecretable peptides, processes for their production, and parallel improvement of the secreted form of one or more other polypeptides
08/29/2002WO2002066622A2 Method of generating diversity into lipolytic enzymes and lipolytic enzyme genes
08/29/2002WO2002066616A2 Engineering fungi for the utilisation of l-arabinose
08/29/2002WO2002066615A2 Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system
08/29/2002WO2002066614A2 Chimeric retinoid x receptors and their use in a novel ecdysone receptor-based inducible gene expression system
08/29/2002WO2002066613A2 Novel ecdysone receptor/invertebrate retinoid x receptor-based inducible gene expression system
08/29/2002WO2002066612A2 Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system
08/29/2002WO2002066513A2 Human circulating lekti fragments hf7072, hf7638 and hf14448 and use thereof
08/29/2002WO2002066507A2 Histidine phosphatase interacting protein of 120 kd
08/29/2002WO2002066505A2 Gmg-3, gmg-4, and gmg-6 polynucleotides and polypeptides and uses thereof
08/29/2002WO2002066494A2 Identification and cloning of a novel human gene, ret16, involved in the intracellular signaling cascade
08/29/2002WO2002065943A2 Ocular tear growth factor-like protein
08/29/2002WO2002065840A2 Consumable product containing probiotics
08/29/2002WO2002065836A2 Delivery systems for mycotechnologies, mycofiltration and mycoremediation
08/29/2002WO2002043649A3 Preparation of compositions comprising bacterial strains and volatile plant extracts and therapeutic and industrial applications thereof
08/29/2002WO2002022795A3 Isolated human kinase proteins, nucleic acid molecules and uses thereof
08/29/2002WO2002020797A3 Genes encoding polypeptides from methylomonas sp. involved exopolysaccharide production
08/29/2002WO2002010403A3 Regulation of human phosphatidylinositol-specific phospholipase c-like enzyme
08/29/2002WO2002010388A3 C3b/C4b COMPLEMENT RECEPTOR-LIKE MOLECULES AND USES THEREOF
08/29/2002WO2001096547A3 Human kinases
08/29/2002WO2001085952A3 Modified inosine 5'-monophosphate dehydrogenase polypeptides and uses thereof
08/29/2002WO2001085944A3 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor
08/29/2002WO2001079284A3 Therapeutic compounds and methods for formulating v3, a versican isoform
08/29/2002WO2001077338A3 Human protein kinases and protein kinase-like enzymes
08/29/2002WO2001070816A3 Ecdysone receptor-based inducible gene expression system
08/29/2002WO2001068848A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/29/2002WO2001064903A3 Novel human transferase proteins and polynucleotides encoding the same
08/29/2002WO2000068382A9 PrP-LIKE GENE
08/29/2002WO2000066709A9 Zymogen activation system
08/29/2002WO2000063245A9 Variant of the plasmodium merozoite surface protein (msp-1) and vaccine comprising said variant
08/29/2002WO2000061606A9 Novel human voltage-gated potassium channel
08/29/2002WO2000060120A9 Methods of detecting microorganism using immobilized probes
08/29/2002WO2000056866A9 Akt-3 nucleic acids, polypeptides, and uses thereof
08/29/2002WO2000055330A9 Polysaturated fatty acid (pufa) elongase from caenorhabditis elegans
08/29/2002WO2000034475A9 Grnf4, a gdnf-related neurotrophic factor
08/29/2002WO2000034474A9 Growth factor homolog zvegf3
08/29/2002WO2000034447A9 Human ubiquitin ligase e3 for the modulation of nf-kappa b
08/29/2002US20020120955 Leaf-specific expression of genes in transgenic plants
08/29/2002US20020120952 Liquid reagent for calcium assay
08/29/2002US20020120125 Polycomb genes from maize - Mez1 and Mez2
08/29/2002US20020120123 Human vascular endothelial growth factor 2
08/29/2002US20020120122 Phosphoserine phosphatase gene of coryneform bacteria
08/29/2002US20020120117 Polynucleotide that exhibits urothelial cell-specific transcriptional response element (TRE) activity; adenoviral vectors which replicate preferentially in urothelial cells; treating bladder cancer for example
08/29/2002US20020120114 Pesticidal toxins and genes from bacillus laterosporus strains
08/29/2002US20020120103 17 human secreted proteins
08/29/2002US20020120102 Native Arg-Gly-Asp (RGD) motif has been deleted or has been replaced by an amino acid sequence having no integrin- binding activity, or an integrin-binding amino acid sequence other than RGD which contains aspartic acid or glutamic acid
08/29/2002US20020119562 Method for selecting improved vectors
08/29/2002US20020119554 Arginase II
08/29/2002US20020119551 ppGpp synthetase and expression systems for improved production of protein of interest
08/29/2002US20020119549 Nucleotide sequences which code for the RPSL gene
08/29/2002US20020119548 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
08/29/2002US20020119537 Which encode the beta-subunit of RNA polymerase B
08/29/2002US20020119526 Nucleic acids encoding a G-protein coupled receptor involved in sensory transduction
08/29/2002US20020119525 TAB1 protein and DNA coding therefore